chronic obstructive pulmonary disease (COPD)
Conditions
Interventions
Test group 1:Randomly conduct two 6-minute walking trials, the first receiving ATOS and the second receiving CFOS.
Test group 2:Randomly conduct two 6-minute walking trials, the first receiving CFOS and the second receiving ATOS.
Sponsors
The Second Hospital & Clinical Medical School, Lanzhou University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. GOLD Stage III to IV patients with stable COPD; 2. FEV1/FVC <70% after inhaled bronchodilators; 3. exclusion of other known etiologies or airflow-restricted diseases with characteristic pathological manifestations; 4. FEV1%pred <=49%.
Exclusion criteria
Exclusion criteria: 1. Acute exacerbation of COPD 2. Surgical or orthopedic patients with severe cardiovascular disease or those whose ability to walk is limited during a walk test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6-min walking distance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Average Oxygen Flow;Transcutaneous Carbon Dioxide Monitoring;Fingertip SpO2 and Heart Rate Monitoring Results During Walking;Borg Scale Assessment;Likert Scale Assessment; | — |
Countries
China
Contacts
Public ContactFangwei Li
The Second Hospital & Clinical Medical School, Lanzhou University
Outcome results
None listed